Zymeworks Inc.

Manager, Investments

Zymeworks Inc.  •  New York City, NY (Remote)  •  6 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description


Zymeworks is a global biotechnology company managing a portfolio of licensed healthcare assets and developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease. The Company’s asset and royalty aggregation strategy focuses on optimizing positive future cash flows from an emerging portfolio of licensed products such as Ziihera® (zanidatamab-hrii) and other licensed products and product candidates such as pasritamig. In addition, Zymeworks is also building a portfolio of healthcare assets that can generate strong cash flows, while supporting the early-stage development of innovative medicines.We are a global company headquartered in Vancouver BC, with operations in Bellevue WA, Dublin IRE, and Singapore.

Why Work With Us

Nothing is more critical to our success than the quality of our team. The work we do is meaningful and impactful - we care about each other as well as the patients we serve. We offer challenging career opportunities, competitive benefits and an environment that recognizes and rewards performance.


This role will be located in New York, USA and is remote.

What You'll Do

  • Perform financial analysis to support the investment process through company- and asset-specific modeling, including the building and maintenance of drug forecasts, operating company models, and royalty monetization and structured investment models.
  • Support the due diligence process by conducting primary research and secondary research through interviews with physician key opinion leaders and consultants and evaluation and review of clinical data, commercial planning materials, competitive landscapes, and other technical diligence areas (IP, manufacturing, payor/market access, legal).
  • Coordinate with relevant cross-functional internal teams as needed to support transaction execution.
  • Prepare high-quality presentation materials including investment presentations and opportunity assessments to support the Investment team in internal reviews and Board-level communications.
  • Manage the investment pipeline to ensure updated record keeping and status tracking of all potential investment opportunities evaluated by the team.
  • Monitor the broader competitive landscape, including deal activity and emerging trends, with regular communications to the Investment team.
  • Take on additional project-based responsibilities as directed to support the growth and effectiveness of the company’s investment function.

What You'll Bring

  • 2 - 5 years of work experience in investment banking, private equity, venture capital, management consulting, corporate development, or a comparable role within the life sciences industry with demonstrated deal or project-based accomplishments.
  • Bachelor’s degree in finance, accounting, economics, or a life science field required with a track record of strong academic performance.
  • Highly motivated team player with a strong work ethic.
  • Intellectual curiosity with an interest in biotechnology, drug development, and investing.
  • Strong written and verbal communication skills with the ability to convey complex information.
  • Robust project management skills, with demonstrated ability to manage multiple concurrent workstreams, meet deadlines, and maintain a high level of attention to detail in a fast-paced environment.
  • Strong analytical and quantitative capabilities, with the ability to synthesize large volumes of scientific, financial, and market data into actionable insights.
  • Adherence to the highest levels of integrity.

Total Rewards

We offer a comprehensive total rewards package, which includes competitive salaries, generous benefits, an outstanding work environment, and excellent opportunities for professional growth. We regularly benchmark our compensation against leading biotechnology companies in our geographies.


The base salary range displayed on each job posting reflects the minimum and maximum target for new hire salaries for the position in the location for which the job is posted and does not include bonus, equity, or benefits. Within the range, individual pay is determined by a variety of factors and the salary offered may vary depending on the successful candidate’s location and qualifications (including, but not limited to, job-related knowledge, education, training, skills, and experience).

Our total rewards package that includes:

  • Industry leading vacation and paid time off
  • Exceptional medical, dental and vision benefits by country
  • Zymelife health and wellness benefits
  • Matching RRSP / 401K / Pension program
  • Employee Share Purchase Program
  • Employee Equity Program
  • Paid time off to volunteer in your community

This role is not eligible for relocation or immigration support.

All qualified applicants will receive consideration for employment without regard to race, colour, religion, sex, sexual orientation, gender identity, national origin or disability.

NOTE TO AGENCIES: Zymeworks values our relationships with our recruiting partners. We only accept resumes from those partners who have been contracted with us. Zymeworks is not responsible for any fees related to resumes that are unsolicited or are received without contract.

Zymeworks Inc.

About Zymeworks Inc.

Zymeworks is a clinical-stage biotechnology company unlocking new possibilities in cancer and autoimmune disease treatment. Our mission is to make a meaningful difference in the lives of patients by advancing a growing pipeline of next-generation antibody therapeutics, including T cell engagers and antibody-drug conjugates (ADCs).

Our lead asset, zanidatamab—a HER2-targeted bispecific antibody— is partnered with Jazz Pharmaceuticals and BeOne Medicines and is approved in the U.S. and China for previously-treated, unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer. Zanidatamab is also being evaluated in multiple global clinical trials as a potential best-in-class treatment for patients with multiple HER2-expressing cancers. We’re also rapidly advancing a robust pipeline of wholly-owned ADC and multispecific programs designed to target areas of significant unmet medical need.

With integrated R&D capabilities and a proven track record of scientific innovation and collaboration, we’re building strategic partnerships and a culture where passionate people can make an impact.

Join us as we engineer what’s next in biotherapeutics.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
Vancouver, CA
Year Founded
2003
Social Media